Armata Pharmaceuticals, Inc.
corporate_fare Company Profile
Armata Pharmaceuticals, Inc. (NYSE:ARMP) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for ARMP at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Recent SEC coverage for ARMP spans 10-Q.
Recent high-impact activity:
- Armata 10-Q: $54.9M Q3 Net Income Is Non-Cash; Going Concern Flagged on $18.3M Cash
Financial Snapshot
Short Interest & Short Volume
9.78 days to coverFINRA reported short interest of 912,610 shares in ARMP as of the October 30, 2026 settlement, a 1.4% increase from the prior period — about 9.8 days to cover at its recent average daily volume. On November 20, 2026, 59.7% of ARMP volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.